《滬深兩市》上證微跌 深成創板半日跌0.8%-2.4% 中移動回吐 寧德時代挫近8%
內地昨日(9日)新增本土確診病例7例。人行今日(10日)進行200億人民幣(下同)7天期逆回購操作,利率持平。人民幣兌美元中間價今上調54點。上證深成微微高開後回軟,創板走弱跌逾2%。
上證半日微跌3點或0.1%,收報3,476點;深成指跌106點或0.8%,收報13,424點;創業板指數跌68點或2.4%,收報2,815點,成交1,309億元。上證深成半日成交分別爲2,491億元及3,383億元。
中資金融股走個別,工行(601398.SH)及建行(601939.SH)分別跌0.4%及0.2%。中國平安(601318.SH)則升1.4%。
中移動(600941.HK)超額發行5,706萬股人民幣股份籌近32億元,同時被納入MSCI中國A在岸指數,股價連升多日後今吐2.5%。
地產股逆市上升,萬科(000002.SZ)、保利發展(600048.SH)及金地集團(600383.SH)升1.6%-4%。
美國光伏電板生產商要求調查中國製造商轉移他國避稅,光伏股顯着下跌,福萊特(601865.SH)及福斯特(603806.SH)分別挫6.5%及7%。
疫情持續緩和,航空及機場股造好,國航(601111.SH)、東航(600115.SH)、南航(600029.SH)及白雲機場(600004.SH)升3%-5.2%。
貴州茅臺(600519.SH)高開低走跌1.5%。公司於春節期間,茅臺酒銷售勢頭向好,價格持續平穩,市場呈現旺銷態勢,其中茅臺醬香系列酒銷售實現大幅增長。
藥明康德A股(603259.SH)續跌6.9%。公司在線上溝通交流會上被問及近期藥明生物(02269.HK)兩家子公司被美國商務部列入UVL事件時強調,藥明康德業務和運營一切正常,藥明康德不在UVL名單中,預計未來也不會被納入該名單。
寧德時代(300750.SZ)挫7.9%。比亞迪(002594.SZ)跌2.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.